Matches 1 - 50 out of 69 1 2 >
Match Document Document Title
7579380 Modified release formulations of a bupropion salt  
The present invention relates to pharmaceutical compositions, formulations and medicaments comprising a bupropion salt, in particular, modified-release tablets comprising an effective amount of...
7425655 Mono di & tri cyclic compounds useful for lowering IgE concentrations  
The present invention is directed novel compounds which are derivatives of minocycline or doxycycline, pharmaceutical compositions containing same and use thereof in lowering excess IgE levels in a...
7384646 Antiseptic disinfectant, and cosmetics and toiletries, medicine or food containing the same  
The purpose of the present invention is to provide antiseptic disinfectant, and cosmetics and toiletries, medicine or food containing the same, which enhance the antibacterial activity that...
7348363 Method of controlling zoological and aquatic plant growth  
A method of controlling target aquatic microorganism pest populations by exposing the target population to an effective amount of an aquacidal compound. The aquacidal compounds are selected from...
7064124 NF-κB inhibitor containing substituted benzoic acid derivative as active ingredient  
A NF-κB inhibitor represented by the following formula (I) is provided:
6984389 Using heat shock proteins to improve the therapeutic benefit of a non-vaccine treatment modality  
The present invention relates to methods of improving a treatment outcome comprising administering a heat shock protein (HSP) preparation or an α-2-macroglobulin (α2M) preparation with a...
6943196 NF-κB inhibitor comprising phenylmethyl benzoquinone as the active ingredient  
An NF-κB inhibitor having as an active ingredient a benzoquinone derivative represented by the general formula (1) wherein R 1 , R 2 , and R 3 are each independently H, alkyl having 1 to 5...
6790463 Uses of targeted oxidative therapeutic formulation in arteriosclerosis  
The use of a pharmaceutical formulation in treating coronary arteriosclerosis and a two-component pharmaceutical formulation. The pharmaceutical formulation contains peroxidic species or reaction...
6677376 Non-peptidic cyclophilin binding compounds and their use  
The invention relates to non-peptidic compounds that possess bioactive properties, such as the ability to protect neuronal cells from otherwise lethal treatments or the ability to promote the...
6673788 Electrophilic ketones for the treatment of herpesvirus infections  
A class of compounds is described which can be used for the treatment of viral infections. Compounds of particular interest are defined by Formula II: wherein each of R 1 , R 2 , and R 3 is...
6670349 Composition & method for altering levels of or sensitivity to adenosine with a dehydroepiandrosterone &/or a ubiquinone  
A method of treating adenosine depletion in a subject in need of such treatment is disclosed. The method comprises administering to the subject folinic acid or a pharmaceutically acceptable salt...
6562332 Attractants of beneficial insects  
The invention provides methods and compositions useful for attracting predatory insects.
6498195 Use of 1-propanone-1-(2,4-dihydroxyphenyl)-3-hydroxy-3-(4′-hydroxyphenyl) as an anticarcinogenic agent  
Compositions and methods are provided for prevention and treatment of cancer. The compositions comprise pure hydroxylated chalcone compounds of licorice root ( Glycyrrhiza glabra ) including...
6492429 Composition for the treatment of osteoarthritis  
Osteoarthritis is treated by a composition containing both apocynin and an inhibitor of inducible nitric oxide synthase such as curcumin. Further components such as boswellic acids, glucosamine,...
6491930 Stable cosmetic formulation containing butylmethoxydibenzoylmethane  
The invention relates e.g. to the use of aldehydes and/or ketones for improving the stability of cosmetic formulations containing butylmethoxydibenzoylmethane as organic light protection filters in...
6458847 Method for screening for drugs useful in inhibition of polymerization of aβ and tau peptides  
A method of stimulating polymerization of a tau protein, comprising the step of contacting said protein with a fatty acid. In another embodiment of the present invention, there is provided a method...
6455578 Aromatic derivatives and iron complexes thereof for the use as normalizing agents of the iron level  
The present invention is directed to aromatic derivatives of formula (I), wherein: R 1 is (a), wherein R 3 and R 4 are selected from between H and OH, provided that R 3 and R 4 are not...
6436423 Product and method for improving avian health  
A product and method for reducing and preventing the ingestion of substrates by avians wherein the substrates are disposed within an avian house. The product is a bird repellent in combination with...
6331555 Treatment of platelet derived growth factor related disorders such as cancers  
The present invention concerns compounds which can inhibit platelet derived growth factor receptor (PDGF-R) activity, preferably such compounds also inhibit the activity other members of the PDGF-R...
6291533 Dietary supplements for each specific blood type  
Dietary supplement compositions designed to be responsive to specific blood types, and thus most beneficial for people with specific antigenic blood types.
6258854 Ketone precursors for organoleptic compounds  
The invention discloses ketones of formula I: ##STR1## wherein, Y is an optionally substituted alkyl, cycloalkyl, or cycloalkylalkyl, wherein each alkyl group is straight or branched and each...
6258836 Dopamine analog amide  
The invention involves the formation of a prodrug from a fatty acid carrier and a neuroactive drug. The prodrug is stable in the environment of both the stomach and the bloodstream and may be...
6177474 Polyhydroxyphenol derivatives and preventive and therapeutic agents for bone and cartilage diseases containing the same  
Compounds useful as preventive and therapeutic agents for bone and cartilage diseases; and drug compositions containing the same. The compounds are polyhydroxyphenol derivatives of general formula...
6177472 Regulation of alzheimer's disease proteins and uses thereof  
A method of regulating the assembly of the protein tau in the brain of a mammal in need of such treatment comprising the step of administering to said mammal a pharmacologically effective amount of...
6087402 Foam cleaning compositions  
The present invention relates to a foam composition for killing dust mites comprising an acaricidal agent, polymer, ether solvent, perfume, surfactant and water.
6087351 Method for reducing adenosine levels with a dehydroepiandrosterone and optionally a ubiquinone  
A method and composition for reducing adenosine levels comprises administering a dehydroepiandrosterone, and optionally a ubiquinone.
5994392 Antipsychotic prodrugs comprising an antipsychotic agent coupled to an unsaturated fatty acid  
The invention involves the formation of a prodrug from a fatty acid carrier and a neuroactive drug. The prodrug is stable in the environment of both the stomach and the bloodstream and may be...
5866569 Naphthalenedione nitric oxide synthase (NOS) inhibitors  
There are disclosed methods useful for the inhibition of inducible nitric oxide synthase by the adminstration of a compound of the formula I:. when R 2 is H then R 1 is selected from the group...
5618547 Control of ectoparasites  
A series of 1,3-propanediones having a perfluoroalkyl group or a perfluorocycloalkyl group on one carbonyl, and a 3,5-disubstituted phenyl group on the other, are useful when administered to...
5508275 Lipid-selective antioxidants and their preparation and use  
Lipid-selective antioxidants of the formula I (A) a (L)(X) a , (I), in which A=an antioxidative component, L=a bridging member, X=a lipophilic...
5492690 Benzoylacetate esters as non-sensitizing chelating photo-protectants  
The subject invention relates to pharmaceutical compositions comprising a safe and effective amount of a compound having the structure: ##STR1## wherein n is 3 or 4; each R is independently alkyl...
5449695 Method for repelling aedes aegyptae using carbocyclic ketones, aldehydes and esters  
Described is the Aedes aegyptae repelling use of aldehydes and ketones having the following structures: (i) mixture of aldehydes defined according to the structure: ##STR1## containing from...
5405599 Method and composition for deterring criminals  
A sprayable composition for deterring criminals, e.g., muggers, robbers, rapists, etc., consists essentially of a sprayable lachrymatory agent, such as MACE (chloroacetophenone) or...
5393776 Tocotrienol analogs in the treatment of hypercholesterolemia and hyperlipidemia  
This invention relates to structurally novel acyclic tocotrienol analogs, which are useful for cholesterol/lipid lowering in cases of hypercholesterolemia and hyperlipidemia, and for...
5294613 Method of treating endotoxic shock in mammals  
This invention provides benzene derivatives, pharmaceutical formulations of those derivatives, and a method of using the derivatives for the treatment of inflammation in mammals.
5288750 Substituted β-diketones  
5059627 Nerve growth factor secretion inducing composition  
A compound of the formula: ##STR1## wherein R 1 is a lower alkyl group; R 2 is a hydrogen atom or an alkyl or alkenyl group which may be substituted; R 3 and R 4 each independently means a...
5055461 Anesthetic oral compositions and methods of use  
Disclosed are oral anesthetic pharmaceutical compositions comprising: (a) from about 0.02% to about 25% of a pharmaceutically acceptable acid salt of a β-aminopropiophenone, such as dyclonine HCl;...
4931473 Anesthetic oral compositions  
Disclosed are oral anesthetic pharmaceutical compositions comprising: (a) from about 0.02% to about 25% of a pharmaceutically acceptable acid salt of a β-aminopropiophenone, such as dyclonine HCl;...
4874780 Anticancer compounds  
Deuterated aromatic aldehydes of the formula: ##STR1## where Ar is substituted phenyl, and derivatives thereof represented by the formula: ##STR2## where Ar is substituted or unsubstituted phenyl,...
4778798 Pharmaceutical compositions having vasodilating and antianoxic activities  
Pharmaceutical compositions having vasodilating and antianoxic activities containing an ubiquinone or Coenzyme Q 10 and a vasodilating compound selected from the groups of ergotamine, Rauwolfia,...
4643994 Novel organic trithio oxides and method for the preparation thereof  
This invention relates to novel organic trithio oxides of the formula: R 1 --X --R--X 1 --R 1 wherein R is selected from --CH 2 CHCH--, ##STR1## and (CH 2 ) 3 ; X is selected from ##STR2##...
4621098 Thioethers and pharmaceutical compositions containing them  
The present invention provides thioethers of the general formula: ##STR1## wherein Ar is a phenyl radical which is optionally substituted one, two or three times by alkyl, alkenyl, alkoxy,...
4613611 Method of treating diabetes mellitus using arylglyoxals  
A method of treating diabetes mellitus using arylglyoxals which are known compounds.
4568696 Synergistic non-steroidal anti-inflammatory compounds and compositions thereof  
Non-steroidal anti-inflammatory compositions comprising a compound of the formula: ##STR1## wherein R 1 is H or OH; and X, Y, X 1 and Y 1 represent hydrogen or halogen, such as chloro, fluoro,...
4474810 Arylglyoxals and their pharmaceutical use  
Arylglyoxals which are new compounds, active as hypoglycemic agents.
4443479 Pharmaceutical methods and compositions using parabenzoquinone  
Bronchial asthma including bronchial spasms associated therewith are treated with pharmaceutical compositions containing small amounts of parabenzoquinone, for instance 2 milliliters of a one part...
4439418 Topical preparations for the treatment of seborrhea and process for inhibiting sebum production  
A topical cosmetic preparation for the treatment of seborrhea containing an antiseborrheically effective amount of at least one compound having the formula ##STR1## wherein Ar represents a member...
4322441 Use of fluorinated beta-diketones as bacteriocides and fungicides  
This invention relates to a process for inhibiting the growth of bacteria and fungi on the animal body and on inanimate surfaces using certain fluorinated beta-diketones.
4321264 α-methyldopa compositions  
The application discloses a pharmaceutical composition for treating hypertension containing (A) L-α-methyl-3,4-dihydroxyphenylalanine and (B) salicylamide, phenylglyoxal or L-ascorbic acid.
Matches 1 - 50 out of 69 1 2 >